Research Funding

Grant Title Grantor Amount Award Date
Heather Louise Schuback, MD
Biologic and clinical implications of ETV6 genomic variations in AML Conquer Cancer Foundation and the American Society of Clinical Oncology and Strike 3 Foundation, Young Investigator Award July 2013 - June 2014
Marie Bleakley, MD
Hope Grant Hyundai Sept. 2012 - Dec. 2014
James M. Olson, MD, PhD
NSF1208554 (Seibel, PI) NSF/University of Washington $19,790, effort: 0.24 calendar Sept. 1, 2012 - Aug. 30, 2016
Julie R. Park, MD
Children's Oncology Group - Phase I pilot consortium formed under the Children's Oncology Group to conduct Phase I clinical research trials NIH/NCI - U01 CA097452-06 Aug. 1, 2012 - July 31, 2017
James M. Olson, MD, PhD
Pilot Funds FHCRC (Olson, PI) Institutional Funds $200,000, effort: 0.24 calendar July 1, 2012 - June 30, 2013
Rebecca A. Gardner, MD
A phase 1 trial of autologous T cells genetically modified to express a CD19 specific chimeric antigen receptor to treat pediatric relapsed acute lymphoblastic leukemia SCRI-CCTR Clinical Research Scholar Program May 2012 - May 2014
Rebecca A. Gardner, MD
Autologous T cells Modified to Target CD19+ Pediatric ALL Rally Foundation May 2012 - May 2013
James M. Olson, MD, PhD
2R01CA114567-06A1 (Olson, PI) NIH NCI $129,143, effort: 1.8 calendar April 18, 2012 - March 31, 2017
James M. Olson, MD, PhD
Contract (Olson, PI) Sanofi Aventis $336,303 (no-cost extension), effort: 0.36 calendar Oct. 27, 2011 - Feb. 28, 2013
Douglas S. Hawkins, MD
Pharmacogenetics of Cyclophosphamide ADRs in Children NIH/NCI $38,844 Sept. 1, 2011 - Aug. 31, 2013
Douglas S. Hawkins, MD
Molecular Targeting in Non-Rhabdomyosarcoma Soft Tissue Sarcoma St. Baldricks Foundation $11,380 Sept. 1, 2011 - Aug. 31, 1914
James M. Olson, MD, PhD
CA100735 (Paddison, PI) Department of Defense / CDMRP $89,402, effort: 0.24 calendar Sept. 1, 2011 - Aug. 31, 2014
Julie R. Park, MD
Pharmacogenetics of Cyclophosphamide ADRs in Children NIH/NCI - R21 CA162059-01 Sept. 1, 2011 - Aug. 31, 2013
Eric J. Chow, MD, MPH
Determinants of late cardiovascular morbidity among survivors of hematopoietic cell transplantation National Cancer Institute Aug. 1, 2011 - July 30, 2016
Marie Bleakley, MD
Damon Runyon Clinical Investigator Award July 2011 - June 2014
Douglas S. Hawkins, MD
Early Phase Trials and Biologic Specimen Collection at Seattle Childrens Hospital Rally Foundation $88,170 July 1, 2011 - June 30, 2012
Rebecca A. Gardner, MD
Engineering a Graft Versus Leukemia Effect into Cord Blood Transplant Alex's Lemonade Stand July 2011 - Sept. 2013
James M. Olson, MD, PhD
1R01CA155360-01 (Olson, PI) NIH NCI $207,500, effort: 0.24 calendar June 7, 2011 - March 31, 2016
James M. Olson, MD, PhD
4R42CA14410-02 (Olson, PI) NIH NCI $441,641 (Phase II), effort: 1.2 calendar May 1, 2011 - Dec. 16, 2012
Dana Matthews, MD
Mechanisms of Race-Based Differences in Factor VIII Immunogenicity in Hemophilia National Institutes of Health Sept. 30, 2010
Marie Bleakley, MD
Career Development Award Paul Calabresi (NCI K12 CA079630) July 2010 - July 2011
James M. Olson, MD, PhD
Contract (Olson, PI) Presage Biosciences, Inc. $53,409, effort: 0.24 calendar Nov. 1, 2009 - Dec. 16, 2012
Douglas Hawkins, MD
Children’s Oncology Group trial AEWS0531 NIH $11,956.00 March 1, 2009
Douglas Hawkins, MD
Children’s Oncology Group trial AEWS0331 NIH $11,956.00 March 1, 2009
Douglas Hawkins, MD
Children’s Oncology Group Soft Tissue Sarcoma Committee Chair NIH $23.913.00 March 1, 2009
Douglas Hawkins, MD
Children’s Oncology Group- cooperative group trial, Institutional Principal NIH $57,390.00 March 1, 2009
Michael Bender, MD
Northwest Sickle Cell Collaborative Washington State Department of Health $100,000.00 Jan. 1, 2009
Michael Bender, MD
Newborn Screening Program Washington State Department of Health $3,299.00 Jan. 1, 2009
Michael Bender, MD
Washington State Sickle Cell Contract Washington State Department of Health $46,183.00 Jan. 1, 2009
Michael Bender, MD
Towards a Canine Model of Fanconi Anemia NIH / NHLBI $28,328.00 Jan. 1, 2009
Michael Bender, MD
Digital DNaseI mapping and footprinting of the mouse genome NIH $89,413.00 Jan. 1, 2009
Eric Chow, MD, MPH
Glucocorticoid pharmacogenetics and obesity after childhood ALL therapy Center for Clinical & Translational Research Pediatric Pilot Award Dec. 1, 2008
Eric Chow, MD, MPH
Unrestricted funds for research support Hyundai Hope on Wheels Cancer Research Scholarship Oct. 1, 2008
K Baker, MD, MS
Abdominal aorta intima-media thickness: a measure of early subclinical atherosclerosis Minnesota Medical Foundation $12,000.00 Aug. 15, 2008
Marie Bleakley, MD
Special Fellow in Clinical Research Award Leukemia and Lymphoma Society July 2008 - June 2010
Eric Chow, MD, MPH
Glucocorticoid pharmacogenetics and obesity after childhood ALL therapy Leukemia & Lymphoma Society July 1, 2008
Eric Chow, MD, MPH
Late cardiovascular morbidity and mortality after allogeneic hematopoietic cell transplantation - a population-based analysis ASBMT $unknown July 1, 2008
Julie Park, MD
NIH-U10 CA098543-05 NIH March 1, 2008 - Feb. 28, 2013
Julie R. Park, MD
Children's Oncology Group Chair's Grant - Chair Neuroblastoma, Chair ANBL0532 NIH/NCI - U10 CA098543-05 March 1, 2008 - Feb. 28, 2013
Marie Bleakley, MD
Millennium New Investigator Award American Society of Bone Marrow Transplant 2008 - 2010
Julie Park, MD
Children's Oncology Group - Phase I Study Chair NIH/NCI - U10 CA97452-06 Aug. 1, 2007 - July 31, 2011
Eric Chow, MD, MPH
A pilot study to determine the prevalence, risk factors, and biomarkers associated with the metabolic syndrome in childhood acute lymphoblastic leukemia survivors, comparing conventional treatment with hematopoietic cell transplantation ASCO/Lance Armstrong Foundation $unknown July 2, 2007
Julie Park, MD
Translation Research for Pediatric Solid Tumors Alex’s Lemonade Stand Foundation $200,000.00 July 1, 2007
K Baker, MD, MS
Gene Therapy for Purine Nucleoside Phosphorylase Deficiency (PNP) NIAID $75,000.00 May 1, 2007
Ann Woolfrey, MD
Adult Leukemia Research Center NIH NCI $242,509.00 March 1, 2007
Julie Park, MD
Phase I-II Safety & Exploratory Pharmacodynamic Study of Intravenous Temsirolimus (CCI-779) in Pediatric Subjects with Relapsed-Refractory Solid Tumors Wyeth Pharmaceuticals Jan. 17, 2007 - Jan. 16, 2010
Ann Woolfrey, MD
Sub-Project- BMT0201 NCI NHLBI Oct. 1, 2006
K Baker, MD, MS
Metabolic Syndrome Following Transplant for Leukemia NIH/NCI $1,497,680.00 Aug. 15, 2006
Ann Woolfrey, MD
Stem Cell Transplantation- Basic Clinical Research NIH/NHLBI $93,800.00 Aug. 1, 2006
Ann Woolfrey, MD
Gene Therapy for Fanconi Anemia NIH $479,927.00 July 24, 2006
K Baker, MD, MS
Metabolic Syndrome in Childhood Cancer Survivors NIH/NCI $2,317,865.00 April 1, 2006
K Baker, MD, MS
FHCRC Survivorship Program Lance Armstrong Foundation $1,700,054.00 Jan. 1, 2006
Eric Chow, MD, MPH
Childhood Cancer Survivor Study is an NCI-funded resource study whose primary goal is to study the late effects among a cohort of childhood cancer survivors NCI $unknown Dec. 1, 2005
Julie Park, MD
Genetic Predisposition to Chemotherapy Toxicity in Children Receiving Cyclophosphamide CHRMC Gift Income Genetic Predisposition to Chemotherapy Toxicity in Children Receiving Cyclophosphamide Endowment Oct. 1, 2005
Marie Bleakley, MD
Fellowship Leukemia and Lymphoma Society of America July 2005 - June 2008
James M. Olson, MD, PhD
5U10 CA98543-09 (Adamson, PI) NCCF COG $12,294 (subcontract), effort: 0.58 calendar March 1, 2005 - Feb. 28, 2014
K Baker, MD, MS
Pediatric Cancer Epidemiology Training Grant National Institutes of Health $1,115,934.00 Sept. 30, 2004
Julie Park, MD
Biology and Therapy of High Risk Neuroblastoma NIH/NCI - P01 CA81403-08 June 1, 2003 - May 31, 2013
Russ Geyer, MD
U10 CA98543 National Childhood Cancer Foundation-NIH/NCI $1,367,150. Jan. 1, 2003 - Feb. 29, 2008
Julie R. Park, MD
Novel therapies for high-risk neuroblastoma NIH/NCI - K23 CA87058-05 July 1, 2002 - June 30, 2007
Russ Geyer, MD
FH #05-103637-03-S0993 FHCRC Damon Runyan $995,000. Jan. 1, 2002 - June 30, 2007
Michael Bender, MD
Maintenance of gene expression in the red cell lineage NIH/NHLBI $545,338.00 Sept. 15, 2000
Julie Park, MD
Targeted Hematopoietic Irradiation for Treatment of High Risk Neuroblastoma 7. CHRMC Gift Income Targeted Hematopoietic Irradiation for Treatment of High Risk Neuroblastoma Endowment Dec. 1, 1999
Michael Bender, MD
Function of Human & Mouse b-Globin Locus Control Regions NIH/NIDDK $378,285.00 April 1, 1992
James M. Olson, MD, PhD
Overlap
Ronald Se-Yuen Cheung, MD, PhD
University of Washington Child Health Research Center NIH
Brandon K. Hadland, MD, PhD
T32 CA009351 NCI: Pediatric Oncology Training Program NCI
Brandon K. Hadland, MD, PhD
K12 CA076930 Career Development in Pediatric and Medical Oncology NIH $